Resistant Hypertension & Sleep Apnea: Common Links & Solutions – Baroreflex Failure, Tracheal Caudal Displacement & ZHT?

Share Article

Coinciding with the Latest World Research, and Searching For No-Mask, No-Surgery Alternative Solutions For Sleep Apnea, Dr. Jin Zhou, DC Is In The Seventh Year of Zhou’s Hypoxicology Therapy (ZHT) for Possible Alternative Solutions to More Medical Conditions Than Sleep Apnea, Such As Resistant Hypertension.

Dr. Jin Zhou, DC at celebrates seventh year of Zhou’s Hypoxicology Therapy (ZHT) clinical research for possible solutions to more medical conditions than sleep apnea, such as resistant hypertension, due to the same possible causes: baroreflex dysfunctions and tracheal caudal displacement (TCD), coincidentally in the wake of latest world research findings on "Difficult to Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies", published this month in the volume 2011 of International Journal of Hypertension.

With obvious and satisfactory clinical benefits from ZHT in early clinical observations for sleep apnea and anecdotal benefits for hypertension, Dr. Zhou is clinically seeking for alternative solutions to sleep apnea and hypertension that are completely supernatural and most economical.

Intriguingly, the new research this month revealed the sparring partnership relationship between resistant hypertension and obstructive sleep apnea, the implantable electrical stimulation of carotid sinus as a most innovative and promising therapy, and calling for more multidisciplinary and comprehensive alternative approaches, while Dr. Zhou’s clinical observational assessment indicated the same clinical picture completely from conservative, natural and alternatives with ZHT. Today, Dr. Zhou initiated new approaches to develop anecdotal success into a systematic clinical alternative for persistent hypertension and sleep apnea.

International Journal of Hypertension Volume 2011 (2011) published four articles on “Difficult to Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies”

Resistant Hypertension and Obstructive Sleep Apnea: The Sparring Partners
Benefits from Treatment and Control of Patients with Resistant Hypertension
Resistant Hypertension Workup and Approach to Treatment
Obesity Hypertension: The Regulatory Role of Leptin

“In treating patients with headache or low back pain by ZHT, patients were observed with anecdotal reports of benefits for difficult to treat hypertension and sleep apnea. After reviewing this issue of International Journal of hypertension, I realized the difficult to find opportunity for the world new challenges: conservative baroreflex and carotid receptor resetting for persistent hypertension and sleep apnea,” said Dr. Jin Zhou, the innovator of Zhou’s Hypoxicology Therapy (ZHT), who coined the word, “Hypoxicology”.

Resistant hypertension may affect up to 30% of people with high blood pressure, and hypertension is considered resistant if a person's blood pressure remains above goal despite taking three medications to lower it. High blood pressure that is under control but still requires four or more medications to treat is also considered resistant to treatment. As its name implies, resistant hypertension is difficult to treat, successful treatment of resistant hypertension requires traditional standard pharmaceutical and alternative but effective solutions, further explained, Dr. Zhou.

“Never claim for cure for any modern medical diagnosis, a natural solution with mother nature human body functions will be the most powerful protections against migraines and sleep apnea,” disclaimed Dr. Zhou.

Worldwide research in the last two or three decades discovered significant evidence suggesting a causative or accessory role of sympathetic nerve activity in the etiology of essential hypertension. The implantable use of electrical carotid baroreceptor stimulation in clinical trials is also supported by initial clinical success and increasing evidence that, in hypertension, the baroreflex undergoes a ‘‘resetting’’ that avoids baroreceptor saturation, thus preserving the reflex ability and buffer zone to cause vasodilation and decrease BP in response to an increase in its activity.

For resistant hypertension research, Dr. Zhou developed a hypothesis that trachea caudal displacement (TCD) and vocal cord dysfunction (VCD) primarily impair baroreflex function of carotid sinus, and the reversal of TCD and VCD as well as volitional resuscitation with upper airway defense reflex may reverse sleep apnea thus benefit persistent hypertension management.

In developing the new ZHT (Zhou’s Hypoxicology Therapy) alternatives for sleep apnea, Dr. Zhou, observed clinically that trachea caudal displacement (TCD) (the windpipe moving downward), resulted from diaphragm malfunction and baroreflex dysfunction, instead of weakened soft appellate as claimed by the mainstream scientists, is the main anatomical pathology for snoring, collapse of the upper airway and frequent breathing stops during the night for people with obstructive sleep apnea. In addition, as Dr. Zhou hypothesized, the dysfunction of the baroreflex, chemoreflex, metabo-reflex, mechanoreflex, psychosomato-reflex and respiration pace-making malfunction, due to psychological, environmental and anatomical causations, are primarily and intricately responsible for the obstructive and central sleep apnea development.

Clinically, ZHT employs unique breathing and reflex exercises in conjunction with chiropractic manual and therapeutic exercises to reset baroreflex and functional fitness of upper airway. ZHT is simple, natural and quick for clinical results. Under ZHT Sleep Apnea Protocol, a patient is expected to see definitive noticeable results on the first visit with increasing uvulo-palatal-pharyngeal space and diaphragm breathing; significant and satisfactory results of both anatomical and functional breathing improvements, and activities of daily living (ADL) improvements within three sessions or if not so, ZHT therapy should be discontinued.

Dr. Jin Zhou, D.C. has been a licensed chiropractic physician in Hanover Park, IL since 1991. He was a former orthopedic surgeon 23 years ago in China. Dr. Zhou is dedicated to developing a revolutionary breakthrough, an extremely simple and super natural therapy that could potentially save millions of lives and trillions of dollars without having to rely upon only medication, surgery and device. He coined the new word, “Hypoxicology”.

For more scientific information on ZHT, please visit, or contact Dr. Jin Zhou at 630-808-7237.

For more clinical information on migraine, please visit, or contact DR. Jin Zhou at 630-736-1646.


Share article on social media or email:

View article via:

Pdf Print